Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Y. Lyou · SciRah

Researcher profile · Semantic Scholar

Y. Lyou

Share profile

Y. Lyou — researcher profile on SciRah

h-index: 15
Works: 53
Citations: 1,675

Most-cited papers

Global Reorganization of Replication Domains During Embryonic Stem Cell Differentiation
Ichiro Hiratani, T. Ryba, M. Itoh, T. Yokochi +6 more
2008PLoS Biology561 citations Open access
Semantic Scholar
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
N. Dizman, L. Meza, P. Bergerot, Marice B. Alcantara +23 more
2022Nature Medicine456 citations Open access
Semantic Scholar
Lactate/pyruvate transporter MCT-1 is a direct Wnt target that confers sensitivity to 3-bromopyruvate in colon cancer
Stephanie Sprowl-Tanio, Amber N. Habowski, Kira T. Pate, Miriam M. McQuade +5 more
2016Cancer & Metabolism89 citations Open access
Semantic Scholar
Machine Learning-Based Interpretation and Visualization of Nonlinear Interactions in Prostate Cancer Survival.
Richard Li, A. Shinde, An Liu, S. Glaser +4 more
2020JCO Clinical Cancer Informatics88 citations Open access
Semantic Scholar
Generation of Functional Eyes from Pluripotent Cells
A. Viczian, E. Solessio, Y. Lyou, M. E. Zuber
2009PLoS Biology76 citations Open access
Semantic Scholar
Inhibition of nuclear Wnt signalling: challenges of an elusive target for cancer therapy
Y. Lyou, Amber N. Habowski, George T. Chen, M. Waterman
2017British Journal of Pharmacology52 citations Open access
Semantic Scholar
Correlates of clinical benefit from immunotherapy and targeted therapy in metastatic renal cell carcinoma: comprehensive genomic and transcriptomic analysis
N. Dizman, Y. Lyou, N. Salgia, P. Bergerot +6 more
2020Journal for ImmunoTherapy of Cancer45 citations Open access
Semantic Scholar
Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma: A Phase 2 Randomized Clinical Trial.
S. Pal, P. Frankel, A. Mortazavi, M. Milowsky +16 more
2021JAMA Oncology37 citations Open access
Semantic Scholar
Wnt/β-Catenin Signaling and Immunotherapy Resistance: Lessons for the Treatment of Urothelial Carcinoma
A. Chehrazi-Raffle, T. Dorff, S. Pal, Y. Lyou
2021Cancers34 citations Open access
Semantic Scholar
Hyperphosphatemia Secondary to the Selective Fibroblast Growth Factor Receptor 1–3 Inhibitor Infigratinib (BGJ398) Is Associated with Antitumor Efficacy in Fibroblast Growth Factor Receptor 3–altered Advanced/Metastatic Urothelial Carcinoma
Y. Lyou, P. Grivas, J. Rosenberg, J. Hoffman-Censits +15 more
2020European Urology26 citations Open access
Semantic Scholar
Maturin is a novel protein required for differentiation during primary neurogenesis
R. I. Martínez-De Luna, R. Y. Ku, Y. Lyou, M. E. Zuber
2013Developmental Biology26 citations Open access
Semantic Scholar
Disruption of beta-catenin dependent Wnt signaling in colon cancer cells remodels the microenvironment to promote tumor invasion
George T. Chen, D. Tifrea, R. Murad, Amber N. Habowski +6 more
2021Molecular Cancer Research21 citations Open access
Semantic Scholar
Advances in Immunotherapy and the TGF-β Resistance Pathway in Metastatic Bladder Cancer
David J. Benjamin, Y. Lyou
2021Cancers21 citations Open access
Semantic Scholar
Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial Carcinoma
Y. Lyou, J. Rosenberg, J. Hoffman-Censits, D. Quinn +15 more
2021Clinical Genitourinary Cancer16 citations Open access
Semantic Scholar
A Practical Guide to Relugolix: Early Experience With Oral Androgen Deprivation Therapy
S. Kasparian, Oren Wei, N. Tsai, Joycelynne Palmer +3 more
2023The Oncologist15 citations Open access
Semantic Scholar
First results of a randomized phase IB study comparing nivolumab/ipilimumab with or without CBM-588 in patients with metastatic renal cell carcinoma.
L. Meza, N. Dizman, P. Bergerot, T. Dorff +16 more
202115 citations
Semantic Scholar
Managing Bladder Cancer Care during the COVID-19 Pandemic Using a Team-Based Approach
Tina Wang, Sariah Liu, T. Joseph, Y. Lyou
2020Journal of Clinical Medicine13 citations Open access
Semantic Scholar
Radiation-Associated Angiosarcoma of the Breast: A Case Report and Literature Review
Y. Lyou, E. Barber, R. Mehta, Thomas Lee +2 more
2018Case Reports in Oncology13 citations Open access
Semantic Scholar
Genomic and Transcriptomic Predictors of Response from Stereotactic Body Radiation Therapy in Patients with Oligoprogressive Renal Cell Carcinoma.
Z. Zengin, Ameish Govindarajan, N. Salgia, N. Sayegh +24 more
2023European Urology Oncology9 citations
Semantic Scholar
Long-Term Outcomes of Patients on a Phase II Prospective Trial of Oligometastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation and External Beam Radiation.
C. Hao, C. Ladbury, Y. Lyou, S. Manoukian +7 more
2022International Journal of Radiation Oncology, Biology, Physics8 citations
Semantic Scholar
Hormonal manipulation in androgen signaling: a narrative review on using novel androgen therapy agents to optimize clinical outcomes and minimize side effects for prostate cancer patients
Y. Lyou, T. Dorff
2021Translational Andrology and Urology6 citations Open access
Semantic Scholar
Reassessing the role of chemoimmunotherapy in chronic lymphocytic leukemia
Yasir Khan, Y. Lyou, M. El-Masry, S. O'Brien
2019Expert Review of Hematology6 citations
Semantic Scholar
Pancytopenia in a patient with cystinosis secondary to myelosuppression from cystine crystal deposition: a case report
Y. Lyou, Xiao-Hui Zhao, C. Nangia
2015Journal of Medical Case Reports6 citations Open access
Semantic Scholar
Prostate Cancer Characteristics and Outcomes after Prostatectomy in Asian-American Men
T. Dorff, James Shen, N. Ruel, R. Kittles +7 more
2021Clinical Genitourinary Cancer5 citations Open access
Semantic Scholar
Infigratinib and treatment response in advanced/unresectable or metastatic urothelial carcinoma in first-line and later-line treatment settings.
Y. Lyou, P. Grivas, J. Rosenberg, J. Hoffman-Censits +13 more
20205 citations
Semantic Scholar
Disrupting ß-catenin dependent Wnt signaling activates an invasive gene program predictive of colon cancer progression
George T. Chen, D. Tifrea, R. Murad, Y. Lyou +3 more
2019bioRxiv4 citations Open access
Semantic Scholar
Mating and sex pheromone related studies with sweetpotato vine borer (Lepidoptera: Pyralidae).
N. Talekar, W.-J. Hu, F.-C. Su, W.-B. Yeh +1 more
19924 citations
Semantic Scholar
Orbital Metastases from Breast Cancer with BRCA2 Mutation: A Case Report and Literature Review
E. Barber, Y. Lyou, R. Mehta, E. Lin +2 more
2018Case Reports in Oncology3 citations Open access
Semantic Scholar
A Patient with Supraclavicular Lymphadenopathy and Anterior Mediastinal Mass Presenting as a Rare Case of Composite Lymphoma: A Case Report and Literature Review
Alexander G. Raufi, James H. Jerkins, Y. Lyou, D. Jeyakumar
2016Case Reports in Oncology3 citations Open access
Semantic Scholar
Perceptions of COVID-19 Vaccination in Patients with Genitourinary Cancers: A Survey Study
Daniela V. Castro, Z. Zengin, J. Malhotra, C. Bergerot +15 more
2022Cancer Investigation2 citations Open access
Semantic Scholar
Chimeric Antigen Receptor (CAR) T-cell Treatment in Renal Cell Carcinoma: Current Clinical Trials and Future Directions
Y. Lyou, T. Dorff
2022Kidney Cancer2 citations Open access
Semantic Scholar
A randomized phase II study comparing cisplatin and gemcitabine with or without berzosertib in patients with advanced urothelial carcinoma.
S. Pal, A. Mortazavi, M. Milowsky, U. Vaishampayan +16 more
20212 citations
Semantic Scholar
Genomic and transcriptomic correlates of clinical benefit from immunotherapy and targeted therapy among patients with metastatic renal cell carcinoma (mRCC).
N. Salgia, N. Dizman, Y. Lyou, P. Bergerot +4 more
2020Journal of Clinical Oncology2 citations
Semantic Scholar
Relationship between hyperphosphatemia with infigratinib (BGJ398) and efficacy in FGFR3-altered advanced/metastatic urothelial carcinoma (aUC).
Y. Lyou, P. Grivas, J. Rosenberg, J. Hoffman-Censits +14 more
2020Journal of Clinical Oncology2 citations
Semantic Scholar
Abstract 385: HIF1A can regulate Wnt signaling in human colon cancer cells
Y. Lyou, George T. Chen, M. Waterman
2018Molecular and Cellular Biology / Genetics2 citations
Semantic Scholar
DISSEMINATED MICROINFARCTIONS WITH CEREBRAL MICROBLEEDS
M. Fisher, K. Kapur, Sylvia Soo, Y. Lyou +2 more
2018Journal of Stroke & Cerebrovascular Diseases2 citations Open access
Semantic Scholar
Extended follow-up report of a randomized phase II trial comparing gemcitabine and cisplatin with or without berzosertib in patients with advanced urothelial carcinoma.
M. Parikh, S. Pal, P. Frankel, C. Ruel +16 more
2024Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Real-world experience with relugolix.
S. Kasparian, Oren Wei, Christopher Lehmer, S. Pal +2 more
2022Journal of Clinical Oncology1 citations
Semantic Scholar
Intestinal microbiome associated with development of grade 3/4 adverse in patients with metastatic renal cell carcinoma (mRCC) treated with nivolumab plus ipilimumab (N/I) and probiotic support: Results from a phase Ib study.
L. Meza, N. Dizman, P. Bergerot, T. Dorff +16 more
2022Journal of Clinical Oncology1 citations
Semantic Scholar
Defining Value in Metastatic Prostate Cancer: What Is the Cost of Living Longer and Better?
T. Dorff, Y. Lyou, C. Stein
2020JCO Oncology Practice1 citations
Semantic Scholar
Global Transcriptional Analysis Reveals Novel Genes Regulated During Early Eye Formation
Y. Lyou, A. Viczian, F. Middleton, M. E. Zuber
20091 citations
Semantic Scholar
150TiP A phase Ib/II trial of a PD-1/VEGF bispecific antibody (PF-08634404) in combination with anticancer agents in first-line (1L) for advanced solid tumors (Symbiotic-Lung-20)
E. Felip, F. Cappuzzo, R. Martins, B. Wang +11 more
2026ESMO Open0 citations Open access
Semantic Scholar
Nivolumab/ipilimumab with or without CBM588 in metastatic renal cell carcinoma: A randomized phase Ib study and the evolution of the functionality of microbial communities with treatment.
N. Dizman, L. Meza, P. Bergerot, Marice B. Alcantara +15 more
2022Journal of Clinical Oncology0 citations
Semantic Scholar
Waning efficacy of COVID-19 vaccination at six months in patients (pts) with genitourinary malignancies.
Z. Zengin, L. Meza, J. Malhotra, S. Salgia +16 more
2022Journal of Clinical Oncology0 citations
Semantic Scholar
Abstract 6293: Genomic characteristics of nivolumab/ipilimumab with or without CBM-588 supplementation in patients with metastatic renal cell carcinoma
Daniela V. Castro, N. Dizman, Z. Zengin, J. Malhotra +11 more
2022Cancer Research0 citations
Semantic Scholar
Association between TERT promoter mutations and clinical outcome with immune checkpoint inhibitor therapy for advanced urothelial cancer.
N. Chawla, N. Tripathi, N. Sayegh, A. Govindarajan +16 more
2022Journal of Clinical Oncology0 citations
Semantic Scholar
High-throughput global transcriptional profiling to identify the STAT3 signaling pathway as a potential biomarker for immune checkpoint inhibitor resistance in metastatic/advanced urothelial carcinoma.
Y. Lyou, T. Dorff, S. Pal, Yate-Ching Yuan
20210 citations
Semantic Scholar
Real-World Utilization And Outcomes Of Radium-223 In The Treatment Of Metastatic Castrate Resistant Prostate Cancer
Richard Li, S. Dandapani, A. Amini, S. Pal +5 more
20200 citations
Semantic Scholar
Abstract 1312: Identifying the genomic correlates of clinical benefit (CB) from immunotherapies (IO) and vascular endothelial growth factor-tyrosine kinase inhibitors (VEGF-TKI) in metastatic renal cell carcinoma (mRCC)
N. Dizman, Sara A. Byron, Y. Lyou, P. Bergerot +5 more
2020Molecular and Cellular Biology / Genetics0 citations
Semantic Scholar
Alkaline Phosphatase And Prostate-Specific Antigen Dynamics And Survival Outcomes In Patients With Metastatic Prostate Cancer Receiving Radium-223
Richard Li, S. Dandapani, A. Amini, S. Pal +5 more
2020International Journal of Radiation Oncology, Biology, Physics0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Pal×27
Invite
S. Pal — researcher profile on SciRah
T. Dorff×19
Invite
T. Dorff — researcher profile on SciRah
N. Dizman×12
Invite
N. Dizman — researcher profile on SciRah
J. Hsu×12
Invite
J. Hsu — researcher profile on SciRah

×9

Invite

L. Meza — researcher profile on SciRah

Invite

Z. Zengin — researcher profile on SciRah

Invite

J. Malhotra — researcher profile on SciRah

Invite

P. Bergerot — researcher profile on SciRah

Invite

N. Chawla — researcher profile on SciRah

A. Chehrazi-Raffle×8

Invite

A. Chehrazi-Raffle — researcher profile on SciRah

Invite

P. Frankel — researcher profile on SciRah

Invite

J. Trent — researcher profile on SciRah